Myeloma plasma cells have been found to induce an imbalance in the OPG/RANKL interactions, increasing RANKL expression and decreasing OPG availability in the bone microenvironment, inducing an enhancement of the osteoclastic activation and increased bone resorption [8, 11]. This evidence concerns the gene TNFRSF11B and plasma cell myeloma.